In a recent study, researchers found no between-group differences in myocardial infarction, stroke or cardiovascular death among patients with prediabetes who received metformin, a lifestyle intervention or placebo.
A review of the data was the top story in cardiology last week.
Another top story explored efforts to improve access to sleep apnea care through cardiology practice accreditation. Raman Malhotra, MD, FAASM, the president of the American Academy of Sleep Medicine, said that cardiologists are “in a unique position” to improve the screening and diagnosis of obstructive